Monday, April 12, 2021 11:54:59 AM
RGEN 0.53%
from $168 to $225.
If someone tries to convince you to buy a stock they usually have a personal agenda to do so. Not because they are concerned about you making money but about convincing you to buy so they can make money. Same is true for those yelling sell.
Recent RGEN News
- Repligen Opens Training & Innovation Center to Elevate Customer Experience • GlobeNewswire Inc. • 09/24/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2024 08:21:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/12/2024 03:35:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/10/2024 08:03:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 12:41:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 11:25:58 PM
- Repligen Corporation to Present at Wells Fargo Healthcare Conference • GlobeNewswire Inc. • 08/23/2024 11:30:00 AM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 08/19/2024 11:29:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 01:56:01 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/02/2024 07:26:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 12:47:55 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 09:04:27 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/01/2024 08:11:55 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/01/2024 08:07:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/30/2024 09:04:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 11:46:52 AM
- Repligen Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 07/30/2024 11:30:00 AM
- Repligen Announces Agreement to Acquire Chromatography Innovator Tantti • GlobeNewswire Inc. • 07/29/2024 08:00:00 PM
- Repligen to Report Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 07/16/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2024 08:05:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 10:07:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 09:42:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 09:41:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 09:33:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 09:15:56 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM